00:00
Growing Money
Growing Money
USD/RUB
EUR/RUB
Releases

Investors Face June 23 Deadline in Regencell Securities Fraud Lawsuit

Investors who lost more than $100,000 in Regencell Bioscience Holdings Limited stock face a critical deadline today. Rosen Law Firm, which has filed a class action lawsuit against the company, is seeking lead plaintiffs to represent shareholders following allegations of misleading statements and market manipulation throughout 2024 and 2025.

Investors Face June 23 Deadline in Regencell Securities Fraud Lawsuit

The lawsuit targets the period between October 28, 2024, and October 31, 2025. Plaintiffs allege that Regencell failed to disclose its vulnerability to market manipulation and the resulting volatility of its ordinary shares. These omissions purportedly exposed shareholders to significant financial risk and heightened regulatory scrutiny, leading to substantial losses when the realities of the company's position surfaced.

Investors who purchased shares during this window are not required to pay out-of-pocket fees to participate, as the case proceeds under a contingency fee arrangement. While a lawsuit is already active, the court requires any parties wishing to serve as lead plaintiff to file their motions by June 23, 2026. Until a class is formally certified, investors remain unrepresented unless they retain their own counsel. Those interested in joining the action or seeking more information can contact Phillip Kim at the Rosen Law Firm via their website or by calling 866-767-3653.

Share

Comments (0)

Leave a comment

No comments yet. Be the first!